Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
229
Frequently Asked Questions
What is Market Cap of Geron Corp.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Geron Corp. market cap is $791.14M.
What is the 52-week high for Geron Corp.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Geron Corp. 52 week high is $4.50 as of October 26, 2025.
What is the 52-week low for Geron Corp.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Geron Corp. 52 week low is $1.09 as of October 26, 2025.
What is Geron Corp. stock price today?
Geron Corp. stock price today is $1.24.
What was Geron Corp. stock price yesterday?
Geron Corp. stock price yesterday was $1.22.
What is the PE ratio of Geron Corp.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Geron Corp.’s P/E ratio is -9.36.
What is the Price-to-Book ratio of Geron Corp.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Geron Corp. P/B ratio is 3.0476.
What is the 50-day moving average of Geron Corp.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Geron Corp. 50-day moving average is $1.34.
